Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Soheila Korourian

Concepts (304)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
30
2018
1203
2.170
Why?
Carcinoma, Ductal, Breast
9
2015
89
1.420
Why?
Mastectomy, Segmental
8
2015
94
1.160
Why?
Catheter Ablation
4
2014
125
1.000
Why?
Neoplasm Recurrence, Local
7
2014
639
0.940
Why?
Sentinel Lymph Node Biopsy
15
2017
119
0.920
Why?
Mastectomy
10
2018
145
0.880
Why?
Mammary Neoplasms, Experimental
7
2010
122
0.790
Why?
Soybean Proteins
4
2023
168
0.760
Why?
Biopsy, Needle
11
2017
181
0.760
Why?
Obesity
8
2023
1176
0.750
Why?
Carcinoma in Situ
3
2008
72
0.730
Why?
Lymph Nodes
12
2017
253
0.710
Why?
Caseins
4
2023
78
0.690
Why?
9,10-Dimethyl-1,2-benzanthracene
4
2015
50
0.670
Why?
Liver
9
2023
1150
0.630
Why?
DNA, Neoplasm
1
2018
146
0.550
Why?
Isoflavones
5
2023
92
0.550
Why?
Rats, Zucker
9
2023
73
0.490
Why?
Uterine Cervical Neoplasms
3
2007
299
0.450
Why?
Receptor, erbB-2
3
2018
79
0.440
Why?
Aged
32
2018
10242
0.420
Why?
Receptors, Estrogen
4
2018
133
0.420
Why?
Arginine
1
2015
183
0.420
Why?
Dietary Supplements
2
2015
470
0.420
Why?
Neoplasm Staging
15
2015
768
0.410
Why?
Female
51
2018
28277
0.400
Why?
Middle Aged
34
2018
13133
0.400
Why?
Mammary Neoplasms, Animal
2
2015
33
0.380
Why?
Diet
2
2015
591
0.370
Why?
Ultrasonography, Mammary
4
2015
61
0.350
Why?
Carcinogens
3
2015
194
0.340
Why?
Fatty Liver
3
2023
141
0.340
Why?
Antigens, Tumor-Associated, Carbohydrate
2
2008
24
0.340
Why?
Benz(a)Anthracenes
1
2010
3
0.340
Why?
Dehydroepiandrosterone
1
2010
14
0.330
Why?
Rats
15
2023
3228
0.330
Why?
Axilla
9
2017
92
0.320
Why?
Lymphatic Vessels
4
2014
38
0.320
Why?
Aged, 80 and over
15
2018
3449
0.310
Why?
Adult
25
2018
14205
0.290
Why?
Plant Lectins
1
2008
8
0.290
Why?
Carcinoma, Ductal
1
2008
7
0.290
Why?
Prognosis
11
2017
2100
0.290
Why?
Magnetic Resonance Imaging
4
2014
1507
0.280
Why?
Technetium Tc 99m Sulfur Colloid
6
2014
31
0.270
Why?
Humans
48
2024
52441
0.270
Why?
Receptors, Progesterone
4
2018
68
0.270
Why?
Electrosurgery
1
2007
9
0.260
Why?
Clinical Competence
2
2024
405
0.260
Why?
Lymphedema
5
2017
47
0.260
Why?
Thinness
3
2017
45
0.260
Why?
Lymphatic Metastasis
12
2015
210
0.250
Why?
Cytodiagnosis
4
2015
42
0.250
Why?
Prospective Studies
12
2017
2433
0.240
Why?
Animals
19
2023
13485
0.240
Why?
Follow-Up Studies
10
2015
2294
0.240
Why?
Combined Modality Therapy
5
2014
641
0.240
Why?
Nipples
5
2013
33
0.240
Why?
Biopsy, Fine-Needle
4
2024
104
0.230
Why?
Adenocarcinoma, Mucinous
1
2005
20
0.230
Why?
Ethanol
5
2010
334
0.220
Why?
Endometritis
1
2004
8
0.220
Why?
Competency-Based Education
1
2024
30
0.220
Why?
Radiopharmaceuticals
6
2014
198
0.220
Why?
Proteoglycans
1
2004
86
0.210
Why?
Carcinoma, Intraductal, Noninfiltrating
3
2013
47
0.210
Why?
Proliferating Cell Nuclear Antigen
1
2003
68
0.200
Why?
Laser Coagulation
1
2003
26
0.200
Why?
Fellowships and Scholarships
1
2024
123
0.200
Why?
Membrane Glycoproteins
1
2004
239
0.200
Why?
Lymph Node Excision
6
2017
133
0.200
Why?
Plasma Cells
1
2004
233
0.200
Why?
Neoplasm Invasiveness
5
2015
278
0.190
Why?
Carcinoma, Lobular
3
2015
32
0.190
Why?
Coloring Agents
4
2014
68
0.190
Why?
Mammaplasty
2
2013
43
0.190
Why?
Infant Food
1
2002
28
0.180
Why?
Uterine Cervical Dysplasia
3
2007
51
0.180
Why?
Monitoring, Intraoperative
3
2014
52
0.180
Why?
Ovarian Neoplasms
1
2005
455
0.170
Why?
Immunohistochemistry
9
2017
977
0.170
Why?
Biopsy
4
2007
594
0.160
Why?
Ultrasonography, Interventional
3
2011
137
0.160
Why?
Paraffin Embedding
2
2018
52
0.160
Why?
Body Weight
3
2017
524
0.150
Why?
Sensitivity and Specificity
8
2015
871
0.150
Why?
Retrospective Studies
13
2015
6694
0.150
Why?
Adolescent
8
2015
6713
0.150
Why?
Lung Neoplasms
3
2015
643
0.150
Why?
Neoplasm Grading
3
2014
127
0.150
Why?
Tissue Fixation
1
2018
35
0.140
Why?
Alanine Transaminase
3
2015
119
0.140
Why?
Specimen Handling
1
2018
59
0.140
Why?
Rats, Sprague-Dawley
7
2015
1558
0.130
Why?
Treatment Outcome
5
2017
5508
0.120
Why?
Pulmonary Medicine
1
2015
15
0.120
Why?
Protein Hydrolysates
1
2015
7
0.120
Why?
Kaplan-Meier Estimate
2
2014
485
0.120
Why?
Aspartate Aminotransferases
1
2015
50
0.120
Why?
Sulfotransferases
1
2015
38
0.110
Why?
Rosaniline Dyes
1
2014
8
0.110
Why?
Image-Guided Biopsy
1
2015
35
0.110
Why?
Dermatologic Surgical Procedures
2
2013
35
0.110
Why?
Melanoma
2
2011
272
0.110
Why?
Plant Extracts
1
2017
199
0.110
Why?
Vacuum
2
2011
11
0.110
Why?
Young Adult
6
2015
4346
0.110
Why?
Interleukin-6
1
2015
271
0.110
Why?
Ultrasonography, Doppler
1
2014
42
0.100
Why?
Tumor Necrosis Factor-alpha
1
2015
390
0.100
Why?
Patient Care Planning
1
2013
68
0.100
Why?
Carcinoma, Adenoid Cystic
1
2013
5
0.100
Why?
Intraoperative Care
2
2011
51
0.100
Why?
Disease-Free Survival
1
2014
461
0.100
Why?
Preoperative Care
1
2014
173
0.100
Why?
Skin Neoplasms
2
2011
496
0.090
Why?
Lymphography
1
2011
8
0.090
Why?
Image Processing, Computer-Assisted
2
2003
234
0.090
Why?
Frozen Sections
1
2011
13
0.090
Why?
Liver Neoplasms
2
2005
341
0.080
Why?
DNA Methylation
1
2015
573
0.080
Why?
Cytoprotection
1
2010
32
0.080
Why?
Male
10
2023
26874
0.080
Why?
Fatty Liver, Alcoholic
1
2010
7
0.080
Why?
Drug Evaluation, Preclinical
1
2010
141
0.080
Why?
Genistein
1
2010
47
0.080
Why?
Cell Line, Tumor
3
2010
1429
0.080
Why?
Feasibility Studies
1
2011
404
0.080
Why?
Hepatocytes
2
2008
184
0.080
Why?
Pilot Projects
1
2011
725
0.070
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2015
1020
0.070
Why?
Radionuclide Imaging
4
2011
101
0.070
Why?
Hepatitis
1
2008
20
0.070
Why?
Nuclear Magnetic Resonance, Biomolecular
1
2007
33
0.070
Why?
Cytokines
2
2008
622
0.070
Why?
Protons
1
2007
74
0.070
Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2007
62
0.060
Why?
Ovariectomy
1
2007
115
0.060
Why?
Organ Size
1
2007
226
0.060
Why?
Oligosaccharides
1
2005
33
0.060
Why?
Cystadenocarcinoma, Papillary
1
2005
14
0.060
Why?
Antibodies, Neoplasm
1
2005
27
0.060
Why?
Omentum
1
2005
16
0.060
Why?
Aging
1
2010
722
0.060
Why?
Uterine Neoplasms
1
2005
57
0.060
Why?
Monosaccharide Transport Proteins
1
2004
14
0.060
Why?
Eosine Yellowish-(YS)
1
2004
6
0.060
Why?
Carcinoma, Small Cell
1
2004
26
0.060
Why?
Hematoxylin
1
2004
7
0.060
Why?
Syndecans
1
2004
37
0.060
Why?
Syndecan-1
1
2004
73
0.050
Why?
Endometrium
1
2004
43
0.050
Why?
Endotoxins
1
2004
23
0.050
Why?
Immunoenzyme Techniques
1
2004
134
0.050
Why?
Carbohydrates
1
2004
41
0.050
Why?
Lymphoma, Non-Hodgkin
1
2004
58
0.050
Why?
Pathology
1
2024
37
0.050
Why?
Liver Diseases, Alcoholic
1
2004
35
0.050
Why?
Cytological Techniques
1
2003
13
0.050
Why?
Apoproteins
1
2003
14
0.050
Why?
Neoplasms, Multiple Primary
1
2003
44
0.050
Why?
Dietary Fats
1
2004
134
0.050
Why?
Malondialdehyde
1
2003
54
0.050
Why?
Fatty Acids
1
2004
152
0.050
Why?
Gene Expression
2
2019
618
0.050
Why?
Gene Expression Regulation
1
2008
1004
0.050
Why?
Neoplasms
2
2004
1314
0.050
Why?
Cell Membrane
1
2004
238
0.050
Why?
Aldehydes
1
2003
81
0.050
Why?
Cytochrome P-450 CYP2E1
3
2010
111
0.050
Why?
Overweight
1
2005
230
0.050
Why?
Risk Factors
1
2011
3971
0.050
Why?
Surgical Instruments
1
2002
29
0.050
Why?
Foreign-Body Migration
1
2002
30
0.050
Why?
Breast Diseases
1
2002
25
0.050
Why?
Education, Medical, Graduate
1
2024
217
0.050
Why?
Hematoma
3
2010
67
0.050
Why?
Asia
1
2002
24
0.050
Why?
Chronic Disease
1
2004
579
0.050
Why?
Carcinoma, Squamous Cell
1
2004
331
0.040
Why?
Head and Neck Neoplasms
1
2004
289
0.040
Why?
Cost-Benefit Analysis
2
2015
271
0.040
Why?
Time Factors
1
2007
2987
0.040
Why?
Neoplasm Metastasis
2
2015
235
0.040
Why?
Health Status
1
2002
300
0.040
Why?
Cytokine Receptor Common beta Subunit
1
2019
2
0.040
Why?
Methyltransferases
1
2019
26
0.040
Why?
Apoptosis
1
2005
1120
0.040
Why?
Disease Progression
2
2015
870
0.040
Why?
Child, Preschool
1
2008
4046
0.040
Why?
Alcohol Dehydrogenase
2
2010
37
0.040
Why?
Cohort Studies
2
2015
1576
0.040
Why?
Arm
2
2009
46
0.040
Why?
Oxidative Stress
3
2010
805
0.040
Why?
Polymerase Chain Reaction
1
2019
458
0.040
Why?
Stereotaxic Techniques
2
2010
41
0.040
Why?
Anti-Bacterial Agents
1
2004
816
0.040
Why?
Risk Assessment
2
2017
1349
0.030
Why?
Disease Models, Animal
2
2015
1483
0.030
Why?
Adiponectin
1
2017
47
0.030
Why?
Reproducibility of Results
2
2015
1223
0.030
Why?
Injections, Intralesional
2
2008
32
0.030
Why?
Feces
1
2017
159
0.030
Why?
Phylogeny
1
2017
229
0.030
Why?
Lipid Metabolism
1
2017
189
0.030
Why?
Leptin
1
2017
148
0.030
Why?
Child
1
2008
7194
0.030
Why?
Cost Savings
1
2015
60
0.030
Why?
Protective Agents
1
2015
16
0.030
Why?
Taxoids
1
2015
38
0.030
Why?
MCF-7 Cells
1
2015
63
0.030
Why?
Mice, Inbred BALB C
2
2005
304
0.030
Why?
CpG Islands
1
2015
111
0.030
Why?
Insulin
1
2017
485
0.030
Why?
Infant, Newborn
1
2002
2871
0.030
Why?
Cyclophosphamide
1
2015
176
0.030
Why?
Tumor Cells, Cultured
1
2015
441
0.030
Why?
Touch
1
2013
25
0.030
Why?
Neoadjuvant Therapy
1
2015
124
0.030
Why?
Biopsy, Large-Core Needle
1
2013
33
0.030
Why?
Carcinoma
1
2015
135
0.030
Why?
Angiogenesis Inhibitors
1
2015
183
0.030
Why?
Infant
1
2002
3709
0.030
Why?
Antibodies, Monoclonal, Humanized
1
2015
230
0.020
Why?
Radiotherapy, Adjuvant
1
2013
65
0.020
Why?
Hormones
1
2013
57
0.020
Why?
Chemotherapy, Adjuvant
1
2013
122
0.020
Why?
Injections, Intradermal
1
2011
14
0.020
Why?
X-Rays
1
2011
55
0.020
Why?
Antineoplastic Agents
2
2013
1216
0.020
Why?
United States
1
2002
5215
0.020
Why?
Cicatrix
1
2011
42
0.020
Why?
Diagnosis, Differential
2
2004
1028
0.020
Why?
Intraoperative Period
1
2011
46
0.020
Why?
Gene Expression Regulation, Neoplastic
1
2015
853
0.020
Why?
Predictive Value of Tests
2
2004
938
0.020
Why?
Allyl Compounds
1
2010
11
0.020
Why?
Sulfides
1
2010
29
0.020
Why?
Survival Rate
1
2012
944
0.020
Why?
Chemokines
1
2010
77
0.020
Why?
Transforming Growth Factor beta1
1
2010
61
0.020
Why?
Double-Blind Method
1
2011
726
0.020
Why?
Mammary Glands, Animal
1
2010
68
0.020
Why?
Endoplasmic Reticulum
1
2010
99
0.020
Why?
Cell Division
1
2010
288
0.020
Why?
Pyrazoles
1
2010
116
0.020
Why?
Pregnancy
1
2015
2642
0.020
Why?
Tissue Extracts
1
2007
13
0.020
Why?
Least-Squares Analysis
1
2007
44
0.020
Why?
Enzyme Inhibitors
1
2010
378
0.020
Why?
Biotransformation
1
2007
83
0.020
Why?
Survival Analysis
1
2009
656
0.020
Why?
Electrocoagulation
1
2007
12
0.020
Why?
Solubility
1
2007
81
0.020
Why?
Observer Variation
1
2007
134
0.020
Why?
Staining and Labeling
1
2007
92
0.020
Why?
Enteral Nutrition
1
2008
154
0.020
Why?
Positron-Emission Tomography
1
2008
297
0.020
Why?
E-Selectin
1
2005
11
0.020
Why?
Body Weights and Measures
1
2005
18
0.010
Why?
Wheat Germ Agglutinins
1
2005
3
0.010
Why?
Vaccines, DNA
1
2005
11
0.010
Why?
Vaccines, Subunit
1
2005
15
0.010
Why?
Gadolinium
1
2005
44
0.010
Why?
Cross Reactions
1
2005
43
0.010
Why?
Growth Inhibitors
1
2005
26
0.010
Why?
Cytotoxicity, Immunologic
1
2005
55
0.010
Why?
Ligands
1
2005
205
0.010
Why?
Gene Amplification
1
2005
59
0.010
Why?
Mice
2
2005
5899
0.010
Why?
Glucose Transporter Type 1
1
2004
17
0.010
Why?
Imaging, Three-Dimensional
1
2005
150
0.010
Why?
Free Radicals
1
2004
27
0.010
Why?
Sampling Studies
1
2004
38
0.010
Why?
In Situ Hybridization, Fluorescence
1
2005
262
0.010
Why?
Enzyme Induction
1
2004
78
0.010
Why?
Contrast Media
1
2005
173
0.010
Why?
Corn Oil
1
2004
12
0.010
Why?
Eye Neoplasms
1
2004
8
0.010
Why?
Hyperplasia
1
2004
96
0.010
Why?
MART-1 Antigen
1
2004
12
0.010
Why?
Amino Acid Sequence
1
2005
576
0.010
Why?
Cell Proliferation
1
2008
1013
0.010
Why?
Species Specificity
1
2004
194
0.010
Why?
Necrosis
1
2004
169
0.010
Why?
Injections
1
2003
60
0.010
Why?
Molecular Sequence Data
1
2005
778
0.010
Why?
Rats, Wistar
1
2004
223
0.010
Why?
Dietary Carbohydrates
1
2004
91
0.010
Why?
Regression Analysis
1
2004
400
0.010
Why?
Cytoplasm
1
2004
93
0.010
Why?
Cytochrome P-450 Enzyme System
1
2004
191
0.010
Why?
Energy Intake
1
2004
183
0.010
Why?
Antigens, Neoplasm
1
2004
145
0.010
Why?
Multivariate Analysis
1
2004
601
0.010
Why?
Cell Nucleus
1
2004
189
0.010
Why?
Glutathione
1
2004
301
0.010
Why?
Sex Characteristics
1
2004
210
0.010
Why?
Antioxidants
1
2004
255
0.010
Why?
Confidence Intervals
1
2002
158
0.010
Why?
Models, Theoretical
1
2002
181
0.010
Why?
Neoplasm Proteins
1
2004
328
0.010
Why?
Reoperation
1
2002
463
0.010
Why?
Korourian's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description